SOMERVILLE MED CTR — All Prescriptions & Medications — Page 4
Practice Code: N85024 | WALLASEY, CH44 4AA
Showing results 151-200 of 637
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Cefalexin | 345 | 15.3K | £939 | +196.6% ▲ |
| Glyceryl trinitrate | 343 | 621 | £865 | +45.0% ▲ |
| Baclofen | 343 | 52.2K | £925 | +71.2% ▲ |
| Bumetanide | 340 | 22.7K | £2.2K | +24.8% ▲ |
| Insulin glargine | 340 | 1,576 | £15.6K | +19.8% ▲ |
| Biphasic insulin aspart | 338 | 2,078 | £12.4K | +232.9% ▲ |
| Loratadine | 330 | 15.2K | £350 | +57.9% ▲ |
| Diclofenac diethyl | 330 | 39.7K | £2.0K | -7.1% ▼ |
| Ferrous sulfate | 326 | 13.5K | £436 | -36.6% ▼ |
| 326 | 134.6K | £2.1K | +23.6% ▲ | |
| Bempedoic acid/Ezetimibe | 321 | 9,415 | £17.7K | +425.7% ▲ |
| Nefopam hydrochloride | 314 | 38.0K | £1.8K | +177.6% ▲ |
| Fluticasone furoate/vilanterol | 309 | 317 | £7.2K | +99.6% ▲ |
| Ready to serve 2.4 kcal/ml milkshake lower volume (0913011) | 307 | 1.7M | £23.6K | +147.8% ▲ |
| Lithium carbonate | 306 | 13.9K | £2.1K | +141.2% ▲ |
| Estradiol with progestogen | 297 | 14.3K | £8.5K | -12.9% ▼ |
| Latanoprost | 297 | 6,425 | £2.0K | -38.8% ▼ |
| Nifedipine | 282 | 15.4K | £4.3K | +50.5% ▲ |
| Rivaroxaban | 282 | 8,514 | £5.8K | -53.9% ▼ |
| Pravastatin sodium | 279 | 8,708 | £443 | -14.1% ▼ |
| Ready to serve 1.5 kcal/ml milkshake (0913011) | 277 | 2.0M | £13.7K | +94.9% ▲ |
| Methylprednisolone acetate | 277 | 302 | £962 | +139.9% ▲ |
| Timolol and bimatoprost | 275 | 3,108 | £3.7K | +81.2% ▲ |
| Lorazepam | 272 | 8,031 | £2.1K | +90.8% ▲ |
| 271 | 3,660 | £695 | +29.7% ▲ | |
| Eplerenone | 263 | 6,970 | £833 | -0.8% vs avg |
| Letrozole | 261 | 7,868 | £695 | +39.8% ▲ |
| Chloramphenicol | 259 | 2,336 | £1.2K | +126.2% ▲ |
| Diltiazem hydrochloride | 255 | 12.5K | £2.1K | -17.0% ▼ |
| Tiotropium bromide/olodaterol | 248 | 254 | £7.8K | +304.4% ▲ |
| Dexamethasone | 247 | 1,520 | £947 | +43.6% ▲ |
| Fluticasone furoate | 244 | 254 | £1.7K | +26.0% ▲ |
| Acetylcysteine | 243 | 6,540 | £1.1K | +239.9% ▲ |
| Estradiol | 241 | 5,624 | £2.7K | -10.7% ▼ |
| Tolterodine | 240 | 7,952 | £2.3K | +61.4% ▲ |
| Moxonidine | 237 | 10.3K | £1.4K | +325.7% ▲ |
| Sacubitril/valsartan | 237 | 13.9K | £22.8K | -1.0% vs avg |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 236 | 7,583 | £754 | +54.5% ▲ |
| Carbomer 940/980 | 236 | 5,150 | £975 | +55.0% ▲ |
| Clonazepam | 234 | 11.3K | £1.7K | +50.2% ▲ |
| Donepezil hydrochloride | 234 | 5,684 | £216 | -24.2% ▼ |
| Mesalazine (Systemic) | 232 | 35.0K | £14.4K | -3.2% ▼ |
| Co-careldopa (Carbidopa/levodopa) | 232 | 23.0K | £1.5K | +2.7% ▲ |
| Ketoconazole | 227 | 33.6K | £5.8K | +131.2% ▲ |
| Pancreatin | 226 | 84.0K | £20.9K | +103.3% ▲ |
| Lymecycline | 226 | 10.2K | £1.3K | +87.9% ▲ |
| Clotrimazole | 224 | 2,756 | £1.6K | +103.0% ▲ |
| Medroxyprogesterone acetate | 224 | 224 | £1.3K | +85.5% ▲ |
| 222 | 22.1K | £1.2K | +69.4% ▲ | |
| Topiramate | 220 | 14.0K | £2.3K | +23.8% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.